A Jin Ten Data News, a Fushen Pharmaceutical, announced in the evening of November 7 that the company plans to accelerate the expansion of the market for microbial protein business. The company intends to invest in the establishment of Fushen Microbial Protein Application Consumer Product Development and Sales Subsidiaries in Shanghai and Singapore, with registered capital of not more than 10 million yuan and 3 million Singapore dollars, respectively.
Ver original
Esta página pode conter conteúdo de terceiros, que é fornecido apenas para fins informativos (não para representações/garantias) e não deve ser considerada como um endosso de suas opiniões pela Gate nem como aconselhamento financeiro ou profissional. Consulte a Isenção de responsabilidade para obter detalhes.
Fuxiang Pharmaceutical: planos para criar subsidiárias em Xangai e Singapura para expandir o negócio de proteínas microbianas
A Jin Ten Data News, a Fushen Pharmaceutical, announced in the evening of November 7 that the company plans to accelerate the expansion of the market for microbial protein business. The company intends to invest in the establishment of Fushen Microbial Protein Application Consumer Product Development and Sales Subsidiaries in Shanghai and Singapore, with registered capital of not more than 10 million yuan and 3 million Singapore dollars, respectively.